Journal of Anaesthesiology Clinical Pharmacology

ORIGINAL ARTICLE
Year
: 2014  |  Volume : 30  |  Issue : 3  |  Page : 366--372

Benefits of intravenous lidocaine on post-operative pain and acute rehabilitation after laparoscopic nephrectomy


Patrick Tauzin-Fin, Olivier Bernard, Musa Sesay, Matthieu Biais, Philippe Richebe, Alice Quinart, Philippe Revel, Francois Sztark 
 Department of Anesthesiology, Bordeaux University Hospital, Place Amélie Raba Léon, Bordeaux cedex, France

Correspondence Address:
Patrick Tauzin-Fin
SAR I Hôpital Pellegrin Tripode, 5 Place Amelie Raba Leon, 33076 Bordeaux Cedex
France

Background and Aims: Intravenous (I.V.) lidocaine has analgesic, antihyperalgesic and anti-inflammatory properties and is known to accelerate the return of bowel function after surgery. We evaluated the effects of I.V. lidocaine on pain management and acute rehabilitation protocol after laparoscopic nephrectomy. Materials and Methods: A total of 47 patients scheduled to undergo laparoscopic nephrectomy were included in a two-phase observational study where I.V. lidocaine (1.5 mg/kg/h) was introduced, in the second phase, during surgery and for 24 h post-operatively. All patients underwent the same post-operative rehabilitation program. Post-operative pain scores, opioid consumption and extent of hyperalgesia were measured. Time to first flatus and 6 min walking test (6MWT) were recorded. Results: Patient demographics were similar in the two phases (n = 22 in each group). Lidocaine significantly reduced morphine consumption (median [25-75% interquartile range]; 8.5 mg [4],[5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17] vs. 25 mg [19],[20],[21],[22],[23],[24],[25],[26],[27],[28],[29],[30],[31],[32] ; P < 0.0001), post-operative pain scores (P < 0.05) and hyperalgesia extent on post-operative day 1-day 2-day 4 (mean ± standard deviation (SD); 1.5 ± 0.9 vs. 4.3 ± 1.2 cm (P < 0.001), 0.6 ± 0.5 vs. 2.8 ± 1.2 cm (P < 0.001) and 0.13 ± 0.3 vs. 1.2 ± 1 cm (P < 0.001), respectively). Time to first flatus (mean ± SD; 29 ± 7 h vs. 48 ± 15 h; P < 0.001) and 6MWT at day 4 (189 ± 50 m vs. 151 ± 53 m; P < 0.001) were significantly enhanced in patients with i.v. lidocaine. Conclusion: Intravenous (I.V.) lidocaine could reduce post-operative morphine consumption and improve post-operative pain management and post-operative recovery after laparoscopic nephrectomy. I.V. lidocaine could contribute to better post-operative rehabilitation.


How to cite this article:
Tauzin-Fin P, Bernard O, Sesay M, Biais M, Richebe P, Quinart A, Revel P, Sztark F. Benefits of intravenous lidocaine on post-operative pain and acute rehabilitation after laparoscopic nephrectomy.J Anaesthesiol Clin Pharmacol 2014;30:366-372


How to cite this URL:
Tauzin-Fin P, Bernard O, Sesay M, Biais M, Richebe P, Quinart A, Revel P, Sztark F. Benefits of intravenous lidocaine on post-operative pain and acute rehabilitation after laparoscopic nephrectomy. J Anaesthesiol Clin Pharmacol [serial online] 2014 [cited 2021 Jan 27 ];30:366-372
Available from: https://www.joacp.org/article.asp?issn=0970-9185;year=2014;volume=30;issue=3;spage=366;epage=372;aulast=Tauzin-Fin;type=0